All News
Filter News
Found 808,890 articles
-
AB Introduces Hassle Free MRI Cochlear Implant Technology - April 8, 2019
4/8/2019
Advanced Bionics Announces the Health Canada Approval of the HiRes™ Ultra 3D Cochlear Implant.
-
Axonics® Appoints Nancy L. Snyderman, M.D. and Jane E. Kiernan to its Board of Directors
4/8/2019
Axonics Modulation Technologies, Inc. announced that Nancy L. Snyderman, M.D. and Jane E. Kiernan have been appointed to the Axonics board of directors, effective immediately.
-
Suicide Prevention Advocates Urge Lawmakers to Fund Suicide Prevention Efforts Across the Commonwealth
4/8/2019
Suicide is the tenth leading cause of death in the United States and the 12th leading cause of death in Massachusetts.
-
GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center
4/8/2019
Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that GeneDesign, Inc. has joined the global organization.
-
Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch
4/8/2019
ARIKAYCE Preliminary U.S. Net Product Sales Approximately $21.0 Million for the First Quarter of 2019
-
US FDA approves ViiV Healthcare’s Dovato (dolutegravir/lamivudine), the first, once-daily, single-tablet, two-drug regimen for treatment-naïve HIV-1 adults
4/8/2019
Approval based on GEMINI pivotal trials in which Dovato achieved non-inferior efficacy compared to a dolutegravir-based, traditional, three-drug regimen through 48 weeks, with no cases of resistance1
-
CytoSorbents to Present at the H.C. Wainwright Global Life Sciences Conference 2019 London
4/8/2019
CytoSorbents Corporation announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will present an overview of the company to European investors, Monday, April 8, 2019, at the H.C. Wainwright Global Life Sciences Conference 2019 in London, England.
-
OncLive® Presents State of the Science Summit™ on Treatment of Hematologic Malignancies
4/8/2019
The summit will feature expert faculty from the Dana-Farber Cancer Institute and Harvard Medical School
-
Concert Pharmaceuticals Announces Decision from Patent Trial and Appeal Board in IPR Proceeding
4/8/2019
Concert Pharmaceuticals, Inc. announced that the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office has issued a final written decision in connection with the inter partes review of U.S. Patent No. 9,249,149.
-
Terns Pharmaceuticals to Present at BioCentury’s 26th Annual Future Leaders in Biotech Industry Conference
4/8/2019
Terns Pharmaceuticals Inc. announced that Randy Halcomb, Ph.D., senior vice president of chemistry and early development, will present a corporate overview and update on the Company’s lead programs at BioCentury’s 26th Annual Future Leaders in the Biotech Industry Conference on Friday, April 12, 2018 at 2pm Eastern Time in room 404/405.
-
Horizon Technology Finance Provides $20 Million Venture Loan Facility to Encore Dermatology
4/8/2019
Horizon Technology Finance Corporation, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today it has provided a $20 million venture loan facility to Encore Dermatology, Inc., of which $15 million has been initially funded.
-
Dubai Government Workshop joins whole UAE in celebration of World Health Day
4/7/2019
Activities held in partnership with Dubai Health Authority
-
Amgen Presents New Data At WCO-IOF-ESCEO 2019 Revealing Osteoporosis Treatment Gap In Europe
4/7/2019
Study Shows 55 Percent of Women Over 70 Years Old are at Risk of Fragility Fractures With 75 Percent of Them not Treated for Osteoporosis
-
AirXpanders and Radformation Announce Co-Marketing Agreement
4/7/2019
Partnership Designed to Bring Improved Workflow to Radiation Oncology Departments
-
Statement by the Prime Minister on World Health Day - April 7, 2019
4/7/2019
The Prime Minister, Justin Trudeau, issued the following statement on World Health Day.
-
A Culture Of Caring: CareCentrix Named A 2019 Top Workplace By Tampa Bay Times
4/7/2019
CareCentrix, the leading provider of home-based post-acute care solutions, is selected as one of the Tampa region's top employers, according to the Tampa Bay Times 2019 Top Workplaces ranking; over half of CareCentrix's more than 800 Tampa region employees completed the survey.
-
Hospital Mixes Up Patients Resulting In Penis Shortening, Impotence, and Incontinence From Unnecessary Prostate Surgery; Jury Awards $12.25 Million Verdict
4/6/2019
Case Tried in Polk County, Iowa by Lead Trial Lawyer Nick Rowley of Trial Lawyers for Justice
-
Positive Treatment Results for BRIXADI™ (buprenorphine) Extended-Release Injection in Fentanyl Positive Patients Presented at the 50th Conference of the American Society of Addiction Medicine
4/6/2019
Phase 3 post-hoc analyses indicate less fentanyl and overall illicit opioid use for weekly/monthly buprenorphine depots versus daily standard treatment
-
Indivior Announces New Study Data in Patients with Moderate to Severe Opioid Use Disorder (OUD) at the 50th ASAM Annual Conference
4/6/2019
Injecting opioid users may benefit from higher maintenance dose of SUBLOCADE™ (buprenorphine extended-release), a once-monthly injection for the treatment of moderate to severe opioid use disorder
-
Advisory - Multiple unauthorized health products sold at Sunrise Lee Chinese Herbs Centre in Calgary, Alberta, may pose serious health risks
4/6/2019
Health Canada is advising consumers that several health products sold at Sunrise Lee Chinese Herbs Centre in Calgary, Alberta, are unauthorized and may pose serious health risks.